vito rebecca
vito rebecca
Unknown affiliation
Verified email at wistar.org
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
75142021
PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression
KHT Paraiso, Y Xiang, VW Rebecca, EV Abel, YA Chen, AC Munko, ...
Cancer research 71 (7), 2750-2760, 2011
5422011
Emerging strategies to effectively target autophagy in cancer
VW Rebecca, RK Amaravadi
Oncogene 35 (1), 1-11, 2016
2172016
The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms
KHT Paraiso, HE Haarberg, E Wood, VW Rebecca, YA Chen, Y Xiang, ...
Clinical cancer research 18 (9), 2502-2514, 2012
1662012
Fibroblasts contribute to melanoma tumor growth and drug resistance
EH Flach, VW Rebecca, M Herlyn, KSM Smalley, ARA Anderson
Molecular pharmaceutics 8 (6), 2039-2049, 2011
1272011
A brief history of melanoma: from mummies to mutations
VW Rebecca, VK Sondak, KSM Smalley
Melanoma research 22 (2), 114, 2012
1082012
A unified approach to targeting the lysosome's degradative and growth signaling roles
VW Rebecca, MC Nicastri, N McLaughlin, C Fennelly, Q McAfee, ...
Cancer discovery 7 (11), 1266-1283, 2017
912017
PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer
VW Rebecca, MC Nicastri, C Fennelly, CI Chude, JS Barber-Rotenberg, ...
Cancer discovery 9 (2), 220-229, 2019
712019
Inhibition of autophagy enhances the effects of the AKT inhibitor MK‐2206 when combined with paclitaxel and carboplatin in BRAF wild‐type melanoma
VW Rebecca, RR Massaro, IV Fedorenko, VK Sondak, ARA Anderson, ...
Pigment cell & melanoma research 27 (3), 465-478, 2014
592014
Inhibition of Wee1, AKT, and CDK4 underlies the efficacy of the HSP90 inhibitor XL888 in an in vivo model of NRAS-mutant melanoma
HE Haarberg, KHT Paraiso, E Wood, VW Rebecca, VK Sondak, ...
Molecular cancer therapeutics 12 (6), 901-912, 2013
562013
Evaluating melanoma drug response and therapeutic escape with quantitative proteomics
VW Rebecca, E Wood, IV Fedorenko, KHT Paraiso, HE Haarberg, Y Chen, ...
Molecular & Cellular Proteomics 13 (7), 1844-1854, 2014
542014
Vertical inhibition of the MAPK pathway enhances therapeutic responses in NRAS‐mutant melanoma
VW Rebecca, GM Alicea, KHT Paraiso, H Lawrence, GT Gibney, ...
Pigment cell & melanoma research 27 (6), 1154-1158, 2014
522014
Guidelines for the use and interpretation of assays for monitoring autophagy 1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
Autophagy 17 (1), 1-382, 2021
442021
Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach
E Kim, V Rebecca, IV Fedorenko, JL Messina, R Mathew, ...
Cancer research 73 (23), 6874-6885, 2013
422013
GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation
JK John, KHT Paraiso, VW Rebecca, LP Cantini, EV Abel, N Pagano, ...
Journal of investigative dermatology 132 (12), 2818-2827, 2012
392012
ER translocation of the MAPK pathway drives therapy resistance in BRAF-mutant melanoma
R Ojha, NM Leli, A Onorati, S Piao, II Verginadis, F Tameire, VW Rebecca, ...
Cancer discovery 9 (3), 396-415, 2019
322019
Paradoxical role for wild-type p53 in driving therapy resistance in melanoma
MR Webster, ME Fane, GM Alicea, S Basu, AV Kossenkov, GE Marino, ...
Molecular cell 77 (3), 633-644. e5, 2020
232020
Phase i trials in melanoma: A framework to translate preclinical findings to the clinic
E Kim, VW Rebecca, KSM Smalley, ARA Anderson
European Journal of Cancer 67, 213-222, 2016
232016
Lysosomes support the degradation, signaling, and mitochondrial metabolism necessary for human epidermal differentiation
CL Monteleon, T Agnihotri, A Dahal, M Liu, VW Rebecca, GL Beatty, ...
Journal of Investigative Dermatology 138 (9), 1945-1954, 2018
212018
Changes in aged fibroblast lipid metabolism induce age-dependent melanoma cell resistance to targeted therapy via the fatty acid transporter FATP2
GM Alicea, VW Rebecca, AR Goldman, ME Fane, SM Douglass, ...
Cancer discovery 10 (9), 1282-1295, 2020
182020
The system can't perform the operation now. Try again later.
Articles 1–20